Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mira

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Journal of Viral Hepatitis|June 24, 2006
Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patientsN Merchante, J Macías, E Ramayo, et al.
Journal of Clinical Microbiology|August 22, 2014
Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatmentJavier R Guelfo, Juan Macias, Karin Neukam, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 24, 2003
Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virusJ Macías, J A Pineda, F Lozano, et al.
AIDS (London, England)|April 13, 2004
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapineJuan Macías, Victor Castellano, Nicolás Merchante, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2006
Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patientsSalvador Vergara, Juan Macías, José A Mira, et al.
Journal of Immunological Methods|January 29, 2017
Corrigendum to "A novel method of sampling gingival crevicular fluid from a mouse model of periodontitis" [J Immunol Methods 438 (2016) 21-25]S Matsuda, A Movila, M Suzuki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2010
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virusJuan A Pineda, Antonio Caruz, Antonio Rivero, et al.
The Journal of Infectious Diseases|October 6, 2005
Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfectionJuan Macias, Miguel A Japón, Carmen Sáez, et al.
Antiviral Therapy|October 1, 2004
Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatmentJosé A Mira, Fernando Lozano, Jesús Santos, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2001
Evidence of increased risk for leishmania infantum infection among HIV-seronegative intravenous drug users from southern SpainJ A Pineda, J Macías, F Morillas, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Journal of Viral Hepatitis|June 24, 2006
Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patientsN Merchante, J Macías, E Ramayo, et al.
Journal of Clinical Microbiology|August 22, 2014
Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatmentJavier R Guelfo, Juan Macias, Karin Neukam, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 24, 2003
Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virusJ Macías, J A Pineda, F Lozano, et al.
AIDS (London, England)|April 13, 2004
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapineJuan Macías, Victor Castellano, Nicolás Merchante, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2006
Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patientsSalvador Vergara, Juan Macías, José A Mira, et al.
Journal of Immunological Methods|January 29, 2017
Corrigendum to "A novel method of sampling gingival crevicular fluid from a mouse model of periodontitis" [J Immunol Methods 438 (2016) 21-25]S Matsuda, A Movila, M Suzuki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2010
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virusJuan A Pineda, Antonio Caruz, Antonio Rivero, et al.
The Journal of Infectious Diseases|October 6, 2005
Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfectionJuan Macias, Miguel A Japón, Carmen Sáez, et al.
Antiviral Therapy|October 1, 2004
Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatmentJosé A Mira, Fernando Lozano, Jesús Santos, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 17, 2001
Evidence of increased risk for leishmania infantum infection among HIV-seronegative intravenous drug users from southern SpainJ A Pineda, J Macías, F Morillas, et al.
Pageof 21